Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Ullah, Mujib ^a   Eucker, Jan ^a   Sittinger, Michael ^a   Ringe, Jochen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CCL25; CCR9; Cell migration; Chemotaxis; Chondrogenically differentiated cells; Stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE CCL25; CHEMOKINE RECEPTOR CCR9; COL2A1 PROTEIN; COLLAGEN TYPE 2; ENDOGLIN; HERMES ANTIGEN; PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 9; CCL25 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR;

ADULT; ARTICLE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CHEMOTAXIS; CHONDROGENESIS; DOWN REGULATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MESENCHYMAL STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL; UPREGULATION; CELL CULTURE; CELL MOTION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; CHONDROGENESIS; HUMANS; MESENCHYMAL STROMAL CELLS; RECEPTORS, CCR;

EID: 84883586762     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt310     Document Type: Article

References (75)

1. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Kang SK, Shin IS, Ko MS, Jo JY, Ra JC, Stem Cells Int 2012 2012 342968 22754575
2. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, Miro X, Miosge N, Cell Stem Cell 2009 4 324 335 10.1016/j.stem.2009. 01.015 19341622
3. Osteogenic differentiation influences stem cell migration out of scaffold-free microspheres. Langenbach F, Naujoks C, Kersten-Thiele PV, Berr K, Depprich RA, Kubler NR, Kogler G, Handschel J, Tissue Eng Part A 2010 16 759 766 10.1089/ten.tea.2009.0131 19772456
4. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. Pranav S, Kelber JA, Lee JW, Wright TN, Vecchio KS, Klemke RL, Chen SC, Biomaterials 2012 33 7064 7070 10.1016/j.biomaterials.2012.06.012 22809641
5. A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice. Trouillas M, Prat M, Doucet C, Ernou I, Laplace-Builhe C, Blancard PS, Holy X, Lataillade JJ, Stem Cell Res Ther 2013 4 1 10.1186/scrt149 23290259
6. Progress and potential for regenerative medicine. Gurtner GC, Callaghan MJ, Longaker MT, Annu Rev Med 2007 58 299 312 10.1146/annurev.med.58.082405. 095329 17076602 (Pubitemid 46706516)
7. Bone marrow cells regenerate infarcted myocardium. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Nature 2001 410 701 705 10.1038/35070587 11287958 (Pubitemid 32290358)
8. Therapeutic potentials of stem cells in cardiac diseases. Strauer BE, Schannwell CM, Brehm M, Minerva Cardioangiol 2009 57 249 267 19274033
9. Stem cells for cardiac repair: status, mechanisms, and new strategies. Mingliang R, Bo Z, Zhengguo W, Stem Cells Int 2011 2011 310928 21776280
10. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Zakharova L, Mastroeni D, Mutlu N, Molina M, Goldman S, Diethrich E, Gaballa MA, Cardiovasc Res 2010 87 40 49 10.1093/cvr/cvq027 20118202
11. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH, Han H, Cytotherapy 2005 7 368 373 10.1080/14653240500238160 16162459 (Pubitemid 41535842)
12. Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity. Liu W, Ren Y, Bossert A, Wang X, Dayawansa S, Tong J, He X, Smith DH, Gelbard HA, Huang JH, PLoS One 2012 7 31675 10.1371/journal.pone.0031675 22347502
13. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D, Med Hypotheses 2008 71 900 908 10.1016/j.mehy.2008.06.042 18786777
14. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H, J Tissue Eng Regen Med 2007 1 74 79 10.1002/term.8 18038395
15. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothellum is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. De Becker A, Van Hummelen P, Bakkus M, Broek IV, De Wever J, De Waele M, Van Riet I, Haematol-Hematol J 2007 92 440 449 10.3324/haematol.10475 (Pubitemid 350144289)
16. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Gutierrez-Fernandez M, Rodriguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdan S, Diez-Tejedor E, Stem Cell Res Ther 2013 4 11 10.1186/scrt159 23356495
17. Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Lee JW, Kim YH, Kim SH, Han SH, Hahn SB, Yonsei Med J 2004 45 41 47 15250049 (Pubitemid 39010732)
18. Clinical applications of mesenchymal stem cells in the treatment of fracture non-union and bone defects. Shekkeris AS, Jaiswal PK, Khan WS, Curr Stem Cell Res Ther 2012 7 127 133 10.2174/157488812799218956 22023633
19. Clinical applications of mesenchymal stem cells. Wang S, Qu X, Zhao RC, J Hematol Oncol 2012 5 19 10.1186/1756-8722-5-19 22546280
20. Articular cartilage: structure, injuries and review of management. Bhosale AM, Richardson JB, Br Med Bull 2008 87 77 95 10.1093/bmb/ldn025 18676397
21. The healing and regeneration of articular cartilage. O'Driscoll SW, J Bone Joint Surg Am 1998 80 1795 1812 9875939 (Pubitemid 29013814)
22. Basic science and surgical treatment options for articular cartilage injuries of the knee. Tetteh ES, Bajaj S, Ghodadra NS, J Orthop Sports Phys Ther 2012 42 243 253 10.2519/jospt.2012.3673 22383075
23. Current strategies for articular cartilage repair. Redman SN, Oldfield SF, Archer CW, Eur Cell Mater 2005 9 23 32 discussion 23-32 15830323 (Pubitemid 41008175)
24. Future of tissue engineering in rheumatic diseases. Ringe J, Haupl T, Sittinger M, Expert Opin Biol Ther 2007 7 283 287 10.1517/14712598.7.3.283 17309320 (Pubitemid 46383471)
25. Tissue engineering in the rheumatic diseases. Ringe J, Sittinger M, Arthritis Res Ther 2009 11 211 10.1186/ar2572 19232063
26. Regenerative medicine in rheumatic disease: progress in tissue engineering. Ringe J, Burmester GR, Sittinger M, Nat Rev Rheumatol 2012 8 493 498 10.1038/nrrheum.2012.98 22782007
27. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L, N Engl J Med 1994 331 889 895 10.1056/ NEJM199410063311401 8078550 (Pubitemid 24299869)
28. Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering. Tang QO, Carasco CF, Gamie Z, Korres N, Mantalaris A, Tsiridis E, Expert Opin Biol Ther 2012 12 1361 1382 10.1517/14712598.2012.707182 22784026
29. Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. de la Fuente R, Abad JL, Garcia-Castro J, Fernandez-Miguel G, Petriz J, Rubio D, Vicario-Abejon C, Guillen P, Gonzalez MA, Bernad A, Exp Cell Res 2004 297 313 328 10.1016/j.yexcr.2004.02.026 15212937 (Pubitemid 38798396)
30. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Barbero A, Ploegert S, Heberer M, Martin I, Arthritis Rheum 2003 48 1315 1325 10.1002/art.10950 12746904 (Pubitemid 36554530)
31. Assessment of the profiling microRNA expression of differentiated and dedifferentiated human adult articular chondrocytes. Lin L, Shen Q, Zhang C, Chen L, Yu C, J Orthop Res 2011 29 1578 1584 10.1002/jor.21423 21462252
32. Chondrocyte moves: clever strategies? Morales TI, Osteoarthritis Cartilage 2007 15 861 871 10.1016/j.joca.2007.02.022 17467303 (Pubitemid 47209262)
33. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M, J Cell Biochem 2007 101 135 146 10.1002/jcb.21172 17295203 (Pubitemid 46652579)
34. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Hara Y, Stolk M, Ringe J, Dehne T, Ladhoff J, Kotsch K, Reutzel-Selke A, Reinke P, Volk HD, Seifert M, Transpl Int 2011 24 1112 1123 10.1111/j.1432-2277.2011.01328.x 21880071
35. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Orbay H, Tobita M, Mizuno H, Stem Cells Int 2012 2012 461718 22666271
36. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH, Am J Sports Med 2010 38 1110 1116 10.1177/0363546509359067 20392971
37. Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Dhinsa BS, Adesida AB, Curr Stem Cell Res Ther 2012 7 143 148 10.2174/157488812799219009 22023635
38. Articular cartilage repair with magnetic mesenchymal stem cells. Kamei G, Kobayashi T, Ohkawa S, Kongcharoensombat W, Adachi N, Takazawa K, Shibuya H, Deie M, Hattori K, Goldberg JL, Ochi M, Am J Sports Med 2013 41 1255 1264 10.1177/0363546513483270 23605221
39. Chemokine profile of human serum from whole blood: migratory effects of CXCL-10 and CXCL-11 on human mesenchymal stem cells. Kalwitz G, Andreas K, Endres M, Neumann K, Notter M, Ringe J, Sittinger M, Kaps C, Connect Tissue Res 2010 51 113 122 10.3109/03008200903111906 20001843
40. The human serum metabolome. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS, PLoS One 2011 6 16957 10.1371/journal.pone.0016957 21359215
41. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. Rajala K, Lindroos B, Hussein SM, Lappalainen RS, Pekkanen-Mattila M, Inzunza J, Rozell B, Miettinen S, Narkilahti S, Kerkelä E, Aalto-Setälä K, Otonkoski T, Suuronen R, Hovatta O, Skottman H, PLoS One 2010 5 10246 10.1371/journal.pone.0010246 20419109
42. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Mannello F, Tonti GA, Stem Cells 2007 25 1603 1609 10.1634/stemcells.2007-0127 17395775 (Pubitemid 47121836)
43. Chemokine regulation of normal and pathologic immune responses. Christopherson K 2nd, Hromas R, Stem Cells 2001 19 388 396 10.1634/stemcells.19- 5-388 11553847 (Pubitemid 32900081)
44. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Endres M, Andreas K, Kalwitz G, Freymann U, Neumann K, Ringe J, Sittinger M, Haupl T, Kaps C, Osteoarthritis Cartilage 2010 18 1458 1466 10.1016/j.joca.2010.08.003 20709179
45. Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1. Parmo-Cabanas M, Garcia-Bernal D, Garcia-Verdugo R, Kremer L, Marquez G, Teixido J, J Leukoc Biol 2007 82 380 391 10.1189/jlb.1206726 17510295 (Pubitemid 47230650)
46. Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors. Liu Z, Klominek J, Anticancer Res 2004 24 1625 1630 15274332 (Pubitemid 38954686)
47. High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA. Vertelov G, Kharazi L, Muralidhar MG, Sanati G, Tankovich T, Kharazi A, Stem Cell Res Ther 2013 4 5 10.1186/scrt153 23295150
48. Hypoxic regulation of mesenchymal stem cell migration: the role of RhoA and HIF-1alpha. Raheja LF, Genetos DC, Wong A, Yellowley CE, Cell Biol Int 2011 35 981 989 10.1042/CBI20100733 21574962
49. Cytokine cues. Seton-Rogers S, Nat Rev Cancer 2011 11 690 21900956
50. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ, J Dent Res 2007 86 306 319 10.1177/154405910708600403 17384024
51. Cc-chemokines in allergic inflammation. Baggiolini M, Dahinden CA, Immunol Today 1994 15 127 133 10.1016/0167-5699(94)90156-2 8172645 (Pubitemid 24076330)
52. Involvement of CC chemokines in gamma delta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway. Penido C, Costa MFS, Souza MC, Costa KA, Candea ALP, Benjamim CF, Henriques MDMO, Int Immunol 2008 20 129 139 10.1093/intimm/dxm128 18056919
53. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. Gonzalo JA, Lloyd CM, Wen DY, Albar JP, Wells TNC, Proudfoot A, Martinez C, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC, J Exp Med 1998 188 157 167 10.1084/jem.188.1.157 9653092 (Pubitemid 28328614)
54. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Stich S, Loch A, Leinhase I, Neumann K, Kaps C, Sittinger M, Ringe J, Eur J Cell Biol 2008 87 365 376 10.1016/j.ejcb.2008.03.009 18501472
55. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair: current views. Phinney DG, Prockop DJ, Stem Cells 2007 25 2896 2902 10.1634/stemcells.2007-0637 17901396 (Pubitemid 350127874)
56. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Binger T, Stich S, Andreas K, Kaps C, Sezer O, Notter M, Sittinger M, Ringe J, Exp Cell Res 2009 315 1468 1479 10.1016/j.yexcr.2008. 12.022 19168060
57. Expression of mucosal chemokines TECK/CCL25 and MEC/CCL28 during fetal development of the ovine mucosal immune system. Meurens F, Whale J, Brownlie R, Dybvig T, Thompson DR, Gerdts V, Immunology 2007 120 544 555 10.1111/j.1365-2567.2006.02532.x 17250588 (Pubitemid 46365014)
58. Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues. Meurens F, Berri M, Whale J, Dybvig T, Strom S, Thompson D, Brownlie R, Townsend HG, Salmon H, Gerdts V, Vet Immunol Immunopathol 2006 113 313 327 10.1016/j.vetimm.2006.05.014 16839611 (Pubitemid 44287086)
59. A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures. Ullah M, Hamouda H, Stich S, Sittinger M, Ringe J, BioRes Open Access 2012 1 297 305 10.1089/biores.2012.0279 23514965
60. Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C, Sittinger M, Ringe J, Cell Tissue Res 2009 336 225 236 10.1007/s00441-009-0768-z 19296133
61. A new mathematical model for relative quantification in real-time RT-PCR. Pfaffl MW, Nucleic Acids Res 2001 29 45 10.1093/nar/29.9.e45 11328886
62. Transdifferentiation of mesenchymal stem cells-derived adipogenic-differentiated cells into osteogenic- or chondrogenic-differentiated cells proceeds via dedifferentiation and has a correlation with cell cycle arresting and driving genes. Ullah M, Stich S, Notter M, Eucker J, Sittinger M, Ringe J, Differentiation 2013 85 78 90 10.1016/j.diff.2013.02.001 23644554
63. TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Vicari AP, Figueroa DJ, Hedrick JA, Foster JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, Bacon KB, Zlotnik A, Immunity 1997 7 291 301 10.1016/S1074-7613(00)80531-2 9285413 (Pubitemid 27392020)
64. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. Wurbel MA, McIntire MG, Dwyer P, Fiebiger E, PLoS One 2011 6 16442 10.1371/journal.pone.0016442 21283540
65. Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro. Lee HJ, Choi BH, Min BH, Park SR, Arthritis Rheum 2009 60 2325 2332 10.1002/art.24786 19644865
66. Chondrogenic potentials of human synovium-derived cells sorted by specific surface markers. Chang CB, Han SA, Kim EM, Lee S, Seong SC, Lee MC, Osteoarthritis Cartilage 2013 21 190 199 10.1016/j.joca.2012.10.005 23069852
67. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. Lu YL, Dhanaraj S, Wang ZW, Bradley DM, Bowman SM, Cole BJ, Binette F, J Orthop Res 2006 24 1261 1270 10.1002/jor.20135 16652342 (Pubitemid 43870889)
68. Ultrastructural study of chondrocytes from fibrillated and non-fibrillated human osteoarthritic cartilage. Kouri JB, Jimenez SA, Quintero M, Chico A, Osteoarthr Cartilage 1996 4 111 125 10.1016/S1063-4584(05)80320-6 (Pubitemid 26226435)
69. Outgrowth of chondrocytes from human articular cartilage explants and expression of alpha-smooth muscle actin. Qiu W, Murray MM, Shortkroff S, Lee CR, Martin SD, Spector M, Wound Repair Regen 2000 8 383 391 10.1111/j.1524-475X. 2000.00383.x 11115150
70. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Maumus M, Guerit D, Toupet K, Jorgensen C, Noel D, Stem Cell Res Ther 2011 2 14 10.1186/scrt55 21457518
71. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Mortier A, Gouwy M, Van Damme J, Proost P, Exp Cell Res 2011 317 642 654 10.1016/j.yexcr.2010.11.016 21146523
72. Using the iHOP information resource to mine the biomedical literature on genes, proteins, and chemical compounds. Hoffmann R, Curr Protoc Bioinformatics 2007 Chapter 1 nit1 16 18428678
73. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. Balcells I, Cirera S, Busk PK, BMC Biotechnol 2011 11 70 10.1186/1472-6750-11-70 21702990
74. In situ isolation of mRNA from individual plant cells: creation of cell-specific cDNA libraries. Karrer EE, Lincoln JE, Hogenhout S, Bennett AB, Bostock RM, Martineau B, Lucas WJ, Gilchrist DG, Alexander D, Proc Natl Acad Sci USA 1995 92 3814 3818 10.1073/pnas.92.9.3814 7731989
75. Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond. Van Linthout S, Stamm C, Schultheiss HP, Tschope C, Cardiol Res Pract 2011 2011 757154 21403844